Asian variant of intravascular lymphoma: Aspects of diagnosis and the role of rituximab

Internal Medicine

Volumn 46, Issue 17, 2007, Pages 1381-1386

  Shimizu, Ikuo ^a   Ichikawa, Naoaki ^a   Yotsumoto, Mihoko ^a   Sumi, Masahiko ^a   Ueno, Mayumi ^a   Kobayashi, Hikaru ^a  

^a NAGANO RED CROSS HOSPITAL   (Japan)

Author keywords

Asian variant; Hemophagocytic syndrome; Intravascular lymphoma; Rituximab; Transjugular liver biopsy

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GLUCOCORTICOID; METHYLPREDNISOLONE; PIRARUBICIN; PREDNISOLONE; PROCARBAZINE; RITUXIMAB; VINCRISTINE; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; VAP CYCLO PROTOCOL; VAP-CYCLO PROTOCOL;

ADULT; AGED; ASIA; BONE MARROW BIOPSY; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER RELAPSE; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL ARTICLE; CLINICAL FEATURE; CYTOPENIA; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FEVER; FOLLOW UP; HEPATOSPLENOMEGALY; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; INTRAVASCULAR LYMPHOMA; LIVER BIOPSY; MALE; MEDICAL RECORD REVIEW; NONHODGKIN LYMPHOMA; PERCUTANEOUS BIOPSY; RETROSPECTIVE STUDY; REVIEW; SPLENECTOMY; TREATMENT OUTCOME; ARTICLE; ASIAN; LARGE CELL LYMPHOMA; METASTASIS; MIDDLE AGED; PATHOLOGY; VASCULAR TUMOR;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASIAN CONTINENTAL ANCESTRY GROUP; CENTRAL NERVOUS SYSTEM NEOPLASMS; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MIDDLE AGED; PREDNISOLONE; RETROSPECTIVE STUDIES; VASCULAR NEOPLASMS; VINCRISTINE;

EID: 34548803581     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.46.0066     Document Type: Review

References (31)

1. Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virgnia, November 1997. Histopathology 36: 69-86, 2000.
2. Ferreri AJ, Campo E, Seymour JF, et al. International Extranodal Lymphoma Study Group (IELSG): Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the "cutaneous variant". Br J Haematol 127: 173-183, 2004.
3. Domizio P, Hall PA, Cotter F, et al. Angiotropic large cell lymphoma (ALCL): morphological, immunohistochemical and genotypic studies with analysis of previous reports. Hematol Oncol 7: 195-206, 1989.
4. Murase T, Nakamura S, Kawauchi K, et al. An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome. Br J Haematol 111: 826-834, 2000.
5. Ferreri AJ, Campo E, Ambrosetti A, et al. Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma. Ann Oncol 15: 1215-1221, 2004.
6. DiGiuseppe JA, Nelson WG, Seifter EJ, Boitnott JK, Mann RB. Intravascular lymphomatosis: a clinicopathological study of 10 cases and assessment of response to chemotherapy. J Clin Oncol 12: 2573-2579, 1994.
7. Kusaba T, Hatta T, Tanda S, et al. Histological analysis on adhesive molecules of renal intravascular large B cell lymphoma treated with CHOP chemotherapy and rituximab. Clin Nephrol 65: 222-226, 2006.
8. Tucker TJ, Bardales RH, Miranda RN. Intravascular lymphomatosis with bone marrow involvement: a case report and review of the literature. Arch Pathol Lab Med 123: 952-956, 1999.
9. Yoshikawa S, Kobayashi H, Kanda S, et al. An Asian variant of intravascular lymphoma diagnosed through splenectomy. Intern Med 41: 1215-1216, 2002.
10. Murase T, Tomita Y, Nakamura S. Clinicopathologic features of intravascular large B-cell lymphoma in Japan: review of the special reference to the Asian variant. Jpn J Clin Hematol 43: 5-11, 2002.
11. Shimazaki C, Inaba T, Shimura K, et al. B-cell lymphoma associated with haemophagocytic syndrome: a clinical, immunological and cytogenetic study. Br J Haematol 104: 672-679, 1999.
12. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403: 503-511, 2000.
13. Murase T, Yamaguchi M, Suzuki R, et al. Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5. Blood 109: 478-485, 2007.
14. Murase T. Asian variant of intravascular large B-cell lymphoma: still a diagnostic enigma? Intern Med 41: 1099-1100, 2002.
15. Narimatsu H, Morishita Y, Saito S, et al. Usefulness of bone marrow aspiration for definite diagnosis of Asian variant of intravascular lymphoma: four autopsied cases. Leuk Lympoma 45: 1611-1616, 2004.
16. DiMichele DM, Mirani G, Wilfredo Canchis P, Trost DW, Talal AH. Transjugular liver biopsy is safe and diagnostic for patients with congenital bleeding disorders and hepatitis C infection. Haemophilia 9: 613-618, 2003.
17. Ichikawa N, Kobayashi H, Ito T, Saito H. Chromosomal aberrations detected after stimulation with lipopolysaccharide in a patient with Asian variant intravascular lymphomatosis. Cancer Genet Cytogenet 120: 83-84, 2000.
18. Yoshikawa S, Kobayashi H, Kanda S, et al. An Asian variant of intravascular lymphoma diagnosed through splenectomy. Intern Med 41: 1215-1216, 2002.
19. Baehring JM, Longtine J, Hochberg FH. A new approach to the diagnosis and treatment of intravascular lymphoma. J Neuroncol 61: 237-248, 2003.
20. Tomita N, Kodama F, Kanamori H, Motomura S, Ishigatsubo Y. Secondary central nervous system lymphoma. Int J Hematol 84: 128-135, 2006.
21. Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346: 235-242, 2002.
22. Bazhenova L, Higginbottom P, Mason J. Intravascular lymphoma: a role for single-agent rituximab. Leuk Lymphoma 47: 337-341, 2006.
23. Alfaro J, Espinoza A, Manriquez M, et al. Intravascular lymphoma treated with anti CD20 monoclonal antibodies. Report of one case. Rev Med Chil 132: 1403-1406, 2004.
24. Koizumi M, Nishimura M, Yokota A, Munekata, S, Kobayashi T, Saito Y. Successful treatment of intravascular malignant lymphomatosis with high-dose chemotherapy and autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 27: 1101-1103, 2001.
25. Yamaguchi M, Kimura M, Watanabe Y, et al. Successful autologous peripheral blood stem cell transplantation for relapsed intravascular lymphomatosis. Bone Marrow Transplant 27: 89-91, 2001.
26. Sawamoto A, Narimatsu H, Suzuki T, Kurahashi S, Sugimoto T, Sugiura I. Long-term remission after autologous peripheral blood stem cell transplantation for relapsed intravascular lymphoma. Bone Marrow Transplant 37: 233-234, 2006.
27. Rose C, Staumont D, Jouet JP. Successful autologous bone marrow transplantation in intravascular lymphomatosis. Br J Haematol 105: 313-314, 1999.
28. Nixon BK, Kussick SJ, Carlon MJ, Rubin BP. Intravascular large B-cell lymphoma involving hemangiomas: an unusual presentation of a rare neoplasm. Mod Pathol 18: 1121-1126, 2005.
29. Terrier B, Aouba A, Vasiliu V, et al. Intravascular lymphoma associated with haemophagocytic syndrome: a very rare entity in western countries. Eur J Haematol 75: 341-345, 2005.
30. Kawa K, Sakata A, Takeshita Y, Inoue M. Diagnosis and treatment of hemophagocytic syndrome. Rinsho Ketsueki 46: 418-423, 2005 (in Japanese).
31. Shimazaki C, Inaba T, Nakagawa M. B-cell lymphoma-associated hemophagocytic syndrome. Leuk Lymphoma 38: 121-130, 2000.